Evaluation of Intermediate Care Clinics for Diabetes
NCT00945204 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1997
Last updated 2012-08-08
Summary
The aim of this trial is to assess the effectiveness of intermediate care clinics for diabetes, compared to usual care.
Conditions
Interventions
- OTHER
-
intermediate care clinics (ICCs)
The ICCs will be community based. Their aim is to support primary care, particularly smaller practices that have the most difficulty achieving good control. They will comprise a multidisciplinary team, and be led by specialist nurses who will place an emphasis on education and self management. Medical care will be provided by a diabetologist. The ICC will work closely with hospital based specialist teams and community services including podiatry and dietetics. Team members will work to local guidelines, adapted from national evidence based guidelines. Guidelines for referral to the ICCs will be common across all sites, and will include people with poorly controlled type 2 diabetes and those with poorly controlled cardiovascular risk factors.
Sponsors & Collaborators
-
Warwick Medical School
collaborator OTHER -
University Hospitals, Leicester
lead OTHER
Principal Investigators
-
Andrew D Wilson, MD · University of Leicester
Study Design
- Allocation
- RANDOMIZED
- Purpose
- HEALTH_SERVICES_RESEARCH
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2007-05-31
- Primary Completion
- 2011-10-31
- Completion
- 2011-10-31
Countries
- United Kingdom
Study Locations
More Related Trials
-
Impact of Dietary Intervention on Weight Change in Subjects With Type 2 Diabetes
NCT01232491 ·Status: COMPLETED ·Phase: PHASE4
-
Comparison of Enteral Products for Tube Fed Patients With Type 2 Diabetes
NCT00544206 ·Status: COMPLETED ·Phase: PHASE2
-
Weight Gain, Eating Patterns, and Development of Body Composition During Initiation of Basal Insulin Therapy in Patients With Type 2 Diabetes: A Comparison of Insulin Detemir and Insulin Glargine
NCT00656422 ·Status: TERMINATED ·Phase: PHASE3
-
Cardiac Rest and Stress Metabolism in Patients With Type 2 Diabetes
NCT04009642 ·Status: COMPLETED
-
A Study of the Effect of LY2189265 on Blood Pressure and Heart Rate in Type 2 Diabetes
NCT01149421 ·Status: COMPLETED ·Phase: PHASE2
-
A Clinical Proof-of-principle Trial in Adult Subjects With Newly Diagnosed Type 1 Diabetes Mellitus Investigating the Effect of NNC0114-0006 and Liraglutide on Preservation of Beta-cell Function
NCT02443155 ·Status: COMPLETED ·Phase: PHASE2
-
Manchester Intermittent and Daily Diet Type 1 Diabetes App Study (MIDDAS-Type 1)
NCT04674384 ·Status: UNKNOWN ·Phase: NA
-
Cooperation of Insulin and GLP-1 on Myocardial Glucose Uptake
NCT01232946 ·Status: COMPLETED ·Phase: NA
-
52 Week Trial of Liraglutide in Type 1 Diabetes
NCT01787916 ·Status: COMPLETED ·Phase: PHASE4
-
Comparison Between Breath Acetone and Blood Beta-Hydroxybutyrate
NCT03299543 ·Status: COMPLETED
-
Incretin-based Therapy in Preclinical Type 1 Diabetes in Adults
NCT02611232 ·Status: UNKNOWN ·Phase: PHASE2
-
Evaluation of the Impact of Intensive Short-Term Drug Therapy in Patients With Type 2 Diabetes Mellitus
NCT04027023 ·Status: UNKNOWN ·Phase: PHASE4
-
Group Lifestyle Intervention for People With New Onset Type 2 Diabetes.
NCT00705952 ·Status: COMPLETED ·Phase: NA
-
A Study Comparing Degu Insulin Liraglutide Injection With Premixed Insulin on the Prognosis of Diabetes Mellitus
NCT06925334 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE4
-
Effect of GLP-1 on Insulin-dose, Risk of Hypoglycemia and Gastric Emptying Rate in Patients With Type 1 Diabetes
NCT00993720 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
AI Models for Non-invasive Glycaemic Event Detection Using ECG in Type 1 Diabetics
NCT05461144 ·Status: NOT_YET_RECRUITING
-
Effectiveness of Glucose Control, β Cell Function in Response to Short-term Insulin Pump Therapy in Type 2 Diabetes
NCT03509324 ·Status: COMPLETED ·Phase: PHASE4
-
Effect of Dulaglutide on Liver Fat in Patients With Type 2 Diabetes and Nonalcoholic Fatty Liver Disease
NCT03590626 ·Status: COMPLETED ·Phase: NA
-
Early Diabetes Intervention Program
NCT01470937 ·Status: COMPLETED ·Phase: PHASE4
-
β-hydroxybutyrate, Glucose Metabolism and Prediabetes
NCT03889210 ·Status: COMPLETED ·Phase: NA
-
Investigation on Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Doses of a Long-acting GLP-1 Analogue in Healthy Male Subjects and Male Subjects With Type 2 Diabetes
NCT01686945 ·Status: COMPLETED ·Phase: PHASE1
-
The Effect of Hyperglycemia on LV Function and Exercise Capacity in Diabetics With and Without Heart Failure.
NCT01071772 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of 48 Hours of Treatment With the Natural Peptide-Hormone GLP-1 in Patients With Chronic Heart Failure
NCT00264199 ·Status: COMPLETED ·Phase: NA
-
Effects of GLP-1 on Chronic Heart Failure
NCT02650596 ·Status: UNKNOWN ·Phase: NA
-
Effect of Liraglutide on Vascular Inflammation in Type-2 Diabetes
NCT03449654 ·Status: COMPLETED ·Phase: PHASE4